Relationship between subclinical hypothyroidism and serum osteoprotegerin level in type 2 diabetic patients

Background Subclinical hypothyroidism (SCH) and osteoprotegerin (OPG) are associated with higher risks of cardiovascular disorders in patients with type 2 diabetes mellitus (T2DM). It is unknown whether diabetic patients with SCH have elevated OPG compared with those with euthyroid and, if so, wheth...

Full description

Bibliographic Details
Main Authors: Eman H El-Adawy, Gehan A Shaker, Amal Seleem
Format: Article
Language:English
Published: SpringerOpen 2017-01-01
Series:The Egyptian Journal of Internal Medicine
Subjects:
Online Access:http://www.esim.eg.net/article.asp?issn=1110-7782;year=2017;volume=29;issue=4;spage=176;epage=180;aulast=El-Adawy
_version_ 1818140088710725632
author Eman H El-Adawy
Gehan A Shaker
Amal Seleem
author_facet Eman H El-Adawy
Gehan A Shaker
Amal Seleem
author_sort Eman H El-Adawy
collection DOAJ
description Background Subclinical hypothyroidism (SCH) and osteoprotegerin (OPG) are associated with higher risks of cardiovascular disorders in patients with type 2 diabetes mellitus (T2DM). It is unknown whether diabetic patients with SCH have elevated OPG compared with those with euthyroid and, if so, whether SCH independently associated with OPG level. Objective The objective was to study the association between SCH and serum OPG level among Egyptian adults with newly diagnosed T2DM. Patients and methods One hundred and fifty patients with newly diagnosed T2DM and 150 healthy controls matched for sex and age were included in the study. Serum OPG, thyroid-stimulating hormone (TSH), free thyroxine, free triiodothyronine, blood glucose, lipid profile, fasting insulin, homeostasis model assessment of insulin resistance (HOMA-IR), and anthropometric measurements were assessed for all participants. Results The prevalence of SCH and elevated level of OPG in the diabetic patients were higher than healthy controls (17.3 vs. 4%, P<0.001; and 14 vs. 4.7%, P=0.02; respectively). Diabetics with SCH demonstrated significantly higher HOMA-IR, serum TSH, and OPG compared with diabetics without SCH. Serum TSH was significantly correlated with total cholesterol (P=0.05), fasting insulin (P=0.01), HOMA-IR (P=0.01), and OPG (P=0.005). Moreover, serum OPG was correlated with waist circumference (P=0.01), fasting insulin (P=0.05), and HOMA-IR (P=0.02). Multiple logistic regression analysis revealed that SCH was associated with serum level of OPG independently of the other significant variables (β=2.49, P=0.01). Conclusion T2DM patients with SCH demonstrate higher level and independent association with serum OPG than those with euthyroid. This result might add new information about the causal relationship between SCH and cardiovascular disorders in such a population.
first_indexed 2024-12-11T10:38:26Z
format Article
id doaj.art-9c0d7c4ea3124b55a67c850ea3cdabec
institution Directory Open Access Journal
issn 1110-7782
2090-9098
language English
last_indexed 2024-12-11T10:38:26Z
publishDate 2017-01-01
publisher SpringerOpen
record_format Article
series The Egyptian Journal of Internal Medicine
spelling doaj.art-9c0d7c4ea3124b55a67c850ea3cdabec2022-12-22T01:10:40ZengSpringerOpenThe Egyptian Journal of Internal Medicine1110-77822090-90982017-01-0129417618010.4103/ejim.ejim_40_17Relationship between subclinical hypothyroidism and serum osteoprotegerin level in type 2 diabetic patientsEman H El-AdawyGehan A ShakerAmal SeleemBackground Subclinical hypothyroidism (SCH) and osteoprotegerin (OPG) are associated with higher risks of cardiovascular disorders in patients with type 2 diabetes mellitus (T2DM). It is unknown whether diabetic patients with SCH have elevated OPG compared with those with euthyroid and, if so, whether SCH independently associated with OPG level. Objective The objective was to study the association between SCH and serum OPG level among Egyptian adults with newly diagnosed T2DM. Patients and methods One hundred and fifty patients with newly diagnosed T2DM and 150 healthy controls matched for sex and age were included in the study. Serum OPG, thyroid-stimulating hormone (TSH), free thyroxine, free triiodothyronine, blood glucose, lipid profile, fasting insulin, homeostasis model assessment of insulin resistance (HOMA-IR), and anthropometric measurements were assessed for all participants. Results The prevalence of SCH and elevated level of OPG in the diabetic patients were higher than healthy controls (17.3 vs. 4%, P<0.001; and 14 vs. 4.7%, P=0.02; respectively). Diabetics with SCH demonstrated significantly higher HOMA-IR, serum TSH, and OPG compared with diabetics without SCH. Serum TSH was significantly correlated with total cholesterol (P=0.05), fasting insulin (P=0.01), HOMA-IR (P=0.01), and OPG (P=0.005). Moreover, serum OPG was correlated with waist circumference (P=0.01), fasting insulin (P=0.05), and HOMA-IR (P=0.02). Multiple logistic regression analysis revealed that SCH was associated with serum level of OPG independently of the other significant variables (β=2.49, P=0.01). Conclusion T2DM patients with SCH demonstrate higher level and independent association with serum OPG than those with euthyroid. This result might add new information about the causal relationship between SCH and cardiovascular disorders in such a population.http://www.esim.eg.net/article.asp?issn=1110-7782;year=2017;volume=29;issue=4;spage=176;epage=180;aulast=El-Adawycardiovascular disordersosteoprotegerinsubclinical hypothyroidismtype 2 diabetes
spellingShingle Eman H El-Adawy
Gehan A Shaker
Amal Seleem
Relationship between subclinical hypothyroidism and serum osteoprotegerin level in type 2 diabetic patients
The Egyptian Journal of Internal Medicine
cardiovascular disorders
osteoprotegerin
subclinical hypothyroidism
type 2 diabetes
title Relationship between subclinical hypothyroidism and serum osteoprotegerin level in type 2 diabetic patients
title_full Relationship between subclinical hypothyroidism and serum osteoprotegerin level in type 2 diabetic patients
title_fullStr Relationship between subclinical hypothyroidism and serum osteoprotegerin level in type 2 diabetic patients
title_full_unstemmed Relationship between subclinical hypothyroidism and serum osteoprotegerin level in type 2 diabetic patients
title_short Relationship between subclinical hypothyroidism and serum osteoprotegerin level in type 2 diabetic patients
title_sort relationship between subclinical hypothyroidism and serum osteoprotegerin level in type 2 diabetic patients
topic cardiovascular disorders
osteoprotegerin
subclinical hypothyroidism
type 2 diabetes
url http://www.esim.eg.net/article.asp?issn=1110-7782;year=2017;volume=29;issue=4;spage=176;epage=180;aulast=El-Adawy
work_keys_str_mv AT emanheladawy relationshipbetweensubclinicalhypothyroidismandserumosteoprotegerinlevelintype2diabeticpatients
AT gehanashaker relationshipbetweensubclinicalhypothyroidismandserumosteoprotegerinlevelintype2diabeticpatients
AT amalseleem relationshipbetweensubclinicalhypothyroidismandserumosteoprotegerinlevelintype2diabeticpatients